Literature DB >> 2564093

Interleukin-2 receptor levels indicating relapse in multiple sclerosis.

K Adachi, T Kumamoto, S Araki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2564093     DOI： 10.1016/s0140-6736(89)90103-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Interleukin 2, soluble interleukin 2 receptor, and interferon-gamma in the suction blister fluids from psoriatic skin.

Authors:  H Takematsu; H Tagami
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis: a pilot study.

Authors:  A Achiron; Z Rotstein; S Noy; S Mashiach; M Dulitzky; R Achiron
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

3.  Optic neuritis in different strains of mice by a recombinant HSV-1 expressing murine interleukin-2.

Authors:  Mandana Zandian; Raelene Belisle; Kevin R Mott; Steven Nusinowitz; Florence M Hofman; Homayon Ghiasi
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

4.  Impact of a Demyelination-Inducing Central Nervous System Virus on Expression of Demyelination Genes in Type 2 Lymphoid Cells.

Authors:  Satoshi Hirose; Mihoko Kato; Kati Tormanen; Pedram Shafiei Jahani; Omid Akbari; Homayon Ghiasi
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

5.  Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.

Authors:  M K Sharief; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

6.  Role of interleukin-2 and herpes simplex virus 1 in central nervous system demyelination in mice.

Authors:  Kevin R Mott; Mandana Zandian; Sariah J Allen; Homayon Ghiasi
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

7.  Inflammatory biomarkers and spontaneous preterm birth among obese women.

Authors:  Matthew B Wallenstein; Laura L Jelliffe-Pawlowski; Wei Yang; Suzan L Carmichael; David K Stevenson; Kelli K Ryckman; Gary M Shaw
Journal:  J Matern Fetal Neonatal Med       Date:  2015-12-23

8.  In vivo relationship of interleukin-2 and soluble IL-2 receptor to blood-brain barrier impairment in patients with active multiple sclerosis.

Authors:  M K Sharief; R Hentges; M Ciardi; E J Thompson
Journal:  J Neurol       Date:  1993-01       Impact factor: 4.849

9.  Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis.

Authors:  M Ott; L Demisch; W Engelhardt; P A Fischer
Journal:  J Neurol       Date:  1993-12       Impact factor: 4.849

10.  IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.

Authors:  Lisa M Maier; Christopher E Lowe; Jason Cooper; Kate Downes; David E Anderson; Christopher Severson; Pamela M Clark; Brian Healy; Neil Walker; Cristin Aubin; Jorge R Oksenberg; Stephen L Hauser; Alistair Compston; Stephen Sawcer; Philip L De Jager; Linda S Wicker; John A Todd; David A Hafler
Journal:  PLoS Genet       Date:  2009-01-02       Impact factor: 5.917
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.